» Articles » PMID: 38674375

Neuroanatomical Correlates of Cognitive Dysfunction in 22q11.2 Deletion Syndrome

Overview
Journal Genes (Basel)
Publisher MDPI
Date 2024 Apr 27
PMID 38674375
Authors
Affiliations
Soon will be listed here.
Abstract

22q11.2 Deletion Syndrome (22q11.2DS), the most common chromosomal microdeletion, presents as a heterogeneous phenotype characterized by an array of anatomical, behavioral, and cognitive abnormalities. Individuals with 22q11.2DS exhibit extensive cognitive deficits, both in overall intellectual capacity and focal challenges in executive functioning, attentional control, perceptual abilities, motor skills, verbal processing, as well as socioemotional operations. Heterogeneity is an intrinsic factor of the deletion's clinical manifestation in these cognitive domains. Structural imaging has identified significant changes in volume, thickness, and surface area. These alterations are closely linked and display region-specific variations with an overall increase in abnormalities following a rostral-caudal gradient. Despite the extensive literature developing around the neurocognitive and neuroanatomical profiles associated with 22q11.2DS, comparatively little research has addressed specific structure-function relationships between aberrant morphological features and deficient cognitive processes. The current review attempts to categorize these limited findings alongside comparisons to populations with phenotypic and structural similarities in order to answer to what degree structural findings can explain the characteristic neurocognitive deficits seen in individuals with 22q11.2DS. In integrating findings from structural neuroimaging and cognitive assessments, this review seeks to characterize structural changes associated with the broad neurocognitive challenges faced by individuals with 22q11.2DS.

Citing Articles

Neuropsychological Profile of 25 Brazilian Patients with 22q11.2 Deletion Syndrome: Effects of Clinical and Socioeconomic Variables.

Pimenta L, Mello C, Benedetto L, de Queiroz Soares D, Kulikowski L, Dantas A Genes (Basel). 2024; 15(5).

PMID: 38790224 PMC: 11121403. DOI: 10.3390/genes15050595.

References
1.
Schaer M, Glaser B, Cuadra M, Debbane M, Thiran J, Eliez S . Congenital heart disease affects local gyrification in 22q11.2 deletion syndrome. Dev Med Child Neurol. 2009; 51(9):746-53. DOI: 10.1111/j.1469-8749.2009.03281.x. View

2.
Overdorp E, Kessels R, Claassen J, Oosterman J . Cognitive impairments associated with medial temporal atrophy and white matter hyperintensities: an MRI study in memory clinic patients. Front Aging Neurosci. 2014; 6:98. PMC: 4034495. DOI: 10.3389/fnagi.2014.00098. View

3.
Campbell L, Azuma R, Ambery F, Stevens A, Smith A, Morris R . Executive functions and memory abilities in children with 22q11.2 deletion syndrome. Aust N Z J Psychiatry. 2010; 44(4):364-71. DOI: 10.3109/00048670903489882. View

4.
Kobrynski L, Sullivan K . Velocardiofacial syndrome, DiGeorge syndrome: the chromosome 22q11.2 deletion syndromes. Lancet. 2007; 370(9596):1443-52. DOI: 10.1016/S0140-6736(07)61601-8. View

5.
Shashi V, Kwapil T, Kaczorowski J, Berry M, Santos C, Howard T . Evidence of gray matter reduction and dysfunction in chromosome 22q11.2 deletion syndrome. Psychiatry Res. 2009; 181(1):1-8. PMC: 2794985. DOI: 10.1016/j.pscychresns.2009.07.003. View